Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and susceptibility to diabetic nephropathy in Chinese type 2 diabetic patients: a meta-analysis.

Chang WW, Zhang L, Yao YS, Su H, Jin YL, Chen Y.

Ren Fail. 2013 Aug;35(7):1038-43. doi: 10.3109/0886022X.2013.810542. Epub 2013 Jul 3. Review.

PMID:
23822721
2.

Is C677T polymorphism in methylenetetrahydrofolate reductase gene a risk factor for diabetic nephropathy or diabetes mellitus in a Chinese population?

Cui WP, Du B, Jia Y, Zhou WH, Liu SM, Cui YC, Ma FZ, Luo P, Miao LN.

Arch Med Res. 2012 Jan;43(1):42-50. doi: 10.1016/j.arcmed.2011.12.003. Epub 2011 Dec 30.

PMID:
22209973
3.

Association between MTHFR C677T polymorphism and diabetic nephropathy in the Chinese population: An updated meta-analysis and review.

Xiong X, Lin XK, Xiao X, Qin DP, Zhou DY, Hu JG, Liu Y, Zhong XS.

Nephrology (Carlton). 2016 Jan;21(1):5-12. doi: 10.1111/nep.12541. Review.

PMID:
26072975
4.

Methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism and diabetic nephropathy susceptibility in patients with type 2 diabetes mellitus.

Zhou TB, Drummen GP, Jiang ZP, Li HY.

Ren Fail. 2015;37(8):1247-59. doi: 10.3109/0886022X.2015.1064743. Epub 2015 Jul 10. Review.

PMID:
26161693
5.
6.

MTHFR 677T variant contributes to diabetic nephropathy risk in Caucasian individuals with type 2 diabetes: a meta-analysis.

Yang S, Zhang J, Feng C, Huang G.

Metabolism. 2013 Apr;62(4):586-94. doi: 10.1016/j.metabol.2012.10.004. Epub 2012 Nov 20. Review.

PMID:
23174406
7.

[Relationship between methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy].

Wang L, Wang J, Xue Y, Chen Y, Zou H.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2001 Aug;18(4):276-8. Chinese.

PMID:
11484165
8.

Methylenetetrahydrofolate reductase C677T polymorphism and type 2 diabetes mellitus in Chinese population: a meta-analysis of 29 case-control studies.

Zhu B, Wu X, Zhi X, Liu L, Zheng Q, Sun G.

PLoS One. 2014 Jul 21;9(7):e102443. doi: 10.1371/journal.pone.0102443. eCollection 2014.

9.

Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis.

Zintzaras E, Uhlig K, Koukoulis GN, Papathanasiou AA, Stefanidis I.

J Hum Genet. 2007;52(11):881-90. Epub 2007 Sep 6.

PMID:
17805475
10.
11.
12.

Association of methylenetetrahydrofolate reductase gene C677T polymorphism with polycystic ovary syndrome risk: a systematic review and meta-analysis update.

Fu LY, Dai LM, Li XG, Zhang K, Bai Y.

Eur J Obstet Gynecol Reprod Biol. 2014 Jan;172:56-61. doi: 10.1016/j.ejogrb.2013.10.001. Epub 2013 Oct 10. Review.

PMID:
24192663
13.

Association between MTHFR C677T polymorphism and diabetic nephropathy in a Chinese population: appraisal of a recent meta-analysis.

Zou YF.

Arch Med Res. 2012 Feb;43(2):166-7; author reply 168-9. doi: 10.1016/j.arcmed.2012.02.007. Epub 2012 Feb 26. No abstract available.

PMID:
22374246
14.

MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients.

Mtiraoui N, Ezzidi I, Chaieb M, Marmouche H, Aouni Z, Chaieb A, Mahjoub T, Vaxillaire M, Almawi WY.

Diabetes Res Clin Pract. 2007 Jan;75(1):99-106. Epub 2006 Jul 7.

PMID:
16828193
15.

Association between methylenetetrahydrofolate reductase C677T polymorphism and epilepsy susceptibility: a meta-analysis.

Wu YL, Yang HY, Ding XX, Zhao X, Chen J, Bi P, Sun YH.

Seizure. 2014 Jun;23(6):411-6. doi: 10.1016/j.seizure.2014.01.018. Epub 2014 Feb 2.

16.

The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and tumor risk: evidence from 134 case-control studies.

Tang M, Wang SQ, Liu BJ, Cao Q, Li BJ, Li PC, Li YF, Qin C, Zhang W.

Mol Biol Rep. 2014 Jul;41(7):4659-73. doi: 10.1007/s11033-014-3337-9. Epub 2014 Apr 18.

PMID:
24744129
17.

Association study between methylenetetrahydrofolate reductase polymorphisms and unexplained recurrent pregnancy loss: a meta-analysis.

Cao Y, Xu J, Zhang Z, Huang X, Zhang A, Wang J, Zheng Q, Fu L, Du J.

Gene. 2013 Feb 10;514(2):105-11. doi: 10.1016/j.gene.2012.10.091. Epub 2012 Nov 29.

PMID:
23201418
18.

The protective effect of methylenetetrahydrofolate reductase C677T polymorphism against prostate cancer risk: Evidence from 23 case-control studies.

Guo S, Jiang X, Chen X, Chen L, Li X, Jia Y.

Gene. 2015 Jul 1;565(1):90-5. doi: 10.1016/j.gene.2015.03.067. Epub 2015 Apr 2.

PMID:
25841988
19.

Genetic polymorphism of MTHFR C677T and premature coronary artery disease susceptibility: A meta-analysis.

Hou X, Chen X, Shi J.

Gene. 2015 Jul 1;565(1):39-44. doi: 10.1016/j.gene.2015.03.062. Epub 2015 Mar 31.

PMID:
25839940
20.

Association between MTHFR C677T polymorphism and diabetic nephropathy or diabetes mellitus risk: need for clarification of data in a recent meta-analysis.

Chang WW, Jin YL, Zhang L, Chen Y, Yao YS.

Arch Med Res. 2012 Apr;43(3):248-9; author reply 250-1. doi: 10.1016/j.arcmed.2012.03.008. Epub 2012 Apr 3. No abstract available.

PMID:
22484213

Supplemental Content

Support Center